| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.08 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.08 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |